Brief Title
CH-EUS in Diagnosis of Inoperable Bile Duct Tumors
Official Title
Contrast-enhanced Endoscopic Ultrasound in Diagnosis of Inoperable Bile Duct Tumors
Brief Summary
VALIDATION OF THE SUPERIORITY OF CONTRAST ENHANCED ENDOSCOPY TO STANDARD ENDOSCOPY IN THE DIAGNOSIS OF BILE DUCT TUMORS
Study Type
Interventional
Primary Outcome
CH-EUS FNA has higher diagnostic accuracy for bile tuct tumors
Condition
Inoperable Disease
Intervention
Endoscopic ultrasound with fine needle biopsy
Study Arms / Comparison Groups
EUS-FNA
Description:
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Procedure
Estimated Enrollment
40
Start Date
January 1, 2022
Completion Date
December 30, 2022
Primary Completion Date
December 30, 2022
Eligibility Criteria
Inclusion Criteria: - Bile duct tumor diagnosed at endoscopic US, CT scan or MRI - INR<1.5; platelets > 50.000 - written consent form Exclusion Criteria: - INR>1.5; platelets < 50.000 - duodenal invasion or stenosis - patients denial - previous treatment for hepato-biliary tumors
Gender
All
Ages
18 Years - 99 Years
Accepts Healthy Volunteers
No
Contacts
Andrada Seicean, Professor, +40727786221, [email protected]
Location Countries
Romania
Location Countries
Romania
Administrative Informations
NCT ID
NCT05418543
Organization ID
1509/03.02.2022
Responsible Party
Principal Investigator
Study Sponsor
Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor
Study Sponsor
Andrada Seicean, Professor, Study Director, [email protected]
Verification Date
June 2022